Patents by Inventor Stephen Alistair Smith

Stephen Alistair Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of thiazolidinediones for the treatment of hyperglycaemia
    Publication number: 20040192737
    Abstract: A method for the treatment of hyperglycaemia wherein plasma glucose levels in the range of from >126 mg/dl to 140 mg/dl, which method comprises administering an effective nontoxic and pharmaceutically acceptable amount of an insulin sensitiser, to a mammal in need thereof.
    Type: Application
    Filed: April 13, 2004
    Publication date: September 30, 2004
    Applicant: SmithKline Beecham p.l.c.
    Inventors: Robin Edwin Buckingham, Stephen Alistair Smith
  • Treatment of diabetes with thiazolidinedione and sulphonylurea
    Publication number: 20040176420
    Abstract: A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser and a sub-maximal amount of an insulin secretagogue, to a mammal in need thereof; and a pharmaceutical composition for use in such method.
    Type: Application
    Filed: March 15, 2004
    Publication date: September 9, 2004
    Applicant: SmithKline Beecham p.l.c.
    Inventors: Robin Edwin Buckingham, Stephen Alistair Smith
  • Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
    Publication number: 20040122060
    Abstract: A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitizer, an insulin secretagogue and a biguanide antihyperglycaemic agent, to a mammal in need thereof; and composition for use in such method.
    Type: Application
    Filed: December 8, 2003
    Publication date: June 24, 2004
    Applicant: SmithKline Beecham p.I.c.
    Inventors: Robin Edwin Buckingham, Stephen Alistair Smith
  • Treatment of diabetes with rosiglitazone and insulin
    Publication number: 20040106543
    Abstract: A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of Compound (I) and insulin to a mammal in need thereof.
    Type: Application
    Filed: November 25, 2003
    Publication date: June 3, 2004
    Applicant: SmithKline Beecham p.l.c.
    Inventor: Stephen Alistair Smith
  • Treatment of diabetes with thiazolidinedione and sulphonylurea
    Publication number: 20040097556
    Abstract: A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser and an insulin secretagogue, to a mammal in need thereof.
    Type: Application
    Filed: November 10, 2003
    Publication date: May 20, 2004
    Applicant: SmithKline Beecham p.l.c.
    Inventor: Stephen Alistair Smith
  • Treatment of diabetes with thiazolidinedione and metformin
    Publication number: 20030109553
    Abstract: A method for the treatment and/or prophylaxis of diabetes mellitus, conditions associated with diabetes mellitus and certain complications thereof, in a mammal which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser and a biguanide antihyperglycaemic agent, to a mammal in need thereof and a pharmaceutical composition comprising an insulin sensitiser and a biguanide antihyperglycaemic agent.
    Type: Application
    Filed: January 10, 2003
    Publication date: June 12, 2003
    Applicant: SmithKline Beecham plc
    Inventor: Stephen Alistair Smith
  • Treatment of diabetes with thiazolidinedione and sulphonylurea
    Publication number: 20030109561
    Abstract: A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser and a sub-maximal amount of an insulin secretagogue, to a mammal in need thereof; and a pharmaceutical composition for use in such method.
    Type: Application
    Filed: January 17, 2003
    Publication date: June 12, 2003
    Applicant: SmithKline Beecham p.l.c.
    Inventors: Robin Edwin Buckingham, Stephen Alistair Smith
  • Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
    Publication number: 20030092750
    Abstract: A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser, an insulin secretagogueand an alpha glucosidase inhibitor antihyperglycaemic agent, to a mammal in need thereof; and composition for use in such method.
    Type: Application
    Filed: December 18, 2002
    Publication date: May 15, 2003
    Applicant: SmithKline Beecham p.l.c.
    Inventors: Robin Edwin Buckingham, Stephen Alistair Smith
  • Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
    Publication number: 20030073645
    Abstract: A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser and an alpha-glucosidase inhibitor antihyperglycaemic agent, to a mammal in need thereof.
    Type: Application
    Filed: November 7, 2002
    Publication date: April 17, 2003
    Applicant: SmithKline Beecham plc
    Inventor: Stephen Alistair Smith
  • Use of thiazolidinediones for the treatment of hyperglycaemia
    Publication number: 20030069283
    Abstract: A method for the treatment of hyperglycaemia wherein plasma glucose levels are in the range of elevated normal to ≦126 mg/dl, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser, to a mammal in need thereof.
    Type: Application
    Filed: December 6, 2002
    Publication date: April 10, 2003
    Applicant: SmithKline Beecham p.l.c.
    Inventors: Robin Edwin Buckingham, Stephen Alistair Smith
  • Treatment of diabetes with thiazolidinedione and sulphonylurea
    Publication number: 20020147226
    Abstract: A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser and an insulin secretagogue, to a mammal in need thereof.
    Type: Application
    Filed: March 21, 2002
    Publication date: October 10, 2002
    Applicant: SmithKline Beecham p.l.c.
    Inventor: Stephen Alistair Smith
  • Use of thiazolidinediones for the treatment of hyperglycaemia
    Publication number: 20020137773
    Abstract: A method for the treatment of hyperglycaemia wherein plasma glucose levels in the range from >126 mg/dl to 140 mg/dl, which method comprises administering an effective nontoxic and pharmaceutically acceptable amount of an insulin sensitizer, to a mammal in need thereof.
    Type: Application
    Filed: May 24, 2002
    Publication date: September 26, 2002
    Applicant: SmithKline Beecham p.1.c.
    Inventors: Robin Edwin Buckingham, Stephen Alistair Smith
  • Treatment of diabetes with thiazolidinedione and metformin
    Publication number: 20020137772
    Abstract: A method for the treatment and/or prophylaxis of diabetes mellitus, conditions associated with diabetes mellitus and certain complications thereof, in a mammal which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser and a biguanidine antihyperglycaemic agent, to a mammal in need thereof and a pharmaceutical composition comprising an insulin sensitiser and a biguanide antihyperglycaemic agent.
    Type: Application
    Filed: March 13, 2002
    Publication date: September 26, 2002
    Applicant: SmithKline Beecham plc
    Inventor: Stephen Alistair Smith
  • Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
    Publication number: 20020123514
    Abstract: A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitizer and an alpha-glucosidase inhibitor antihyperglycaemic agent, to a mammal in need thereof.
    Type: Application
    Filed: March 5, 2002
    Publication date: September 5, 2002
    Applicant: SmithKline Beecham plc
    Inventor: Stephen Alistair Smith
  • Use of thiazolidinediones for the treatment of hyperglycaemia
    Publication number: 20020082284
    Abstract: A method for the treatment of hyperglycaemia wherein plasma glucose levels are in the range of elevated normal to ≦126 mg/dl, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser, to a mammal in need thereof.
    Type: Application
    Filed: February 27, 2002
    Publication date: June 27, 2002
    Inventors: Robin Edwin Buckingham, Stephen Alistair Smith
  • Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
    Publication number: 20020052324
    Abstract: A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitizer, an insulin secretagogue and an alpha glucosidase inhibitor antihyperglycaemic agent, to a mammal in need thereof; and composition for use in such method.
    Type: Application
    Filed: November 20, 2001
    Publication date: May 2, 2002
    Applicant: SmithKline Beecham plc
    Inventors: Robin Edwin Buckingham, Stephen Alistair Smith
  • Treatment of diabetes with thiazolidinedione and sulphonylurea
    Publication number: 20020045649
    Abstract: A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser and a sub-maximal amount of an insulin secretagogue, to a mammal in need thereof; and a pharmaceutical composition for use in such method.
    Type: Application
    Filed: October 12, 2001
    Publication date: April 18, 2002
    Applicant: SmithKline Beecham p.l.c.
    Inventors: Robin Edwin Buckingham, Stephen Alistair Smith
  • Treatment of diabetes with rosiglitazone and insulin
    Publication number: 20020028768
    Abstract: A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of Compound (I) and insulin to a mammal in need thereof.
    Type: Application
    Filed: August 13, 2001
    Publication date: March 7, 2002
    Applicant: SmithKline Beecham p.l.c.
    Inventor: Stephen Alistair Smith
  • Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
    Publication number: 20020016287
    Abstract: A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser, an insulin secretagogue and a biguanide antihyperglycaemic agent, to a mammal in need thereof; and composition for use in such method.
    Type: Application
    Filed: August 24, 2001
    Publication date: February 7, 2002
    Applicant: SmithKline Beecham p.l.c.
    Inventors: Robin Edwin Buckingham, Stephen Alistair Smith
  • Use of thiazolidinediones for the treatment of hyperglycaemia
    Publication number: 20020006939
    Abstract: A method for the treatment of hyperglycaemia wherein plasma glucose levels in the range of from >126 mg/dl to 140 mg/dl, which method comprises administering an effective nontoxic and pharmaceutically acceptable amount of an insulin sensitizer, to a mammal in need thereof.
    Type: Application
    Filed: September 10, 2001
    Publication date: January 17, 2002
    Applicant: SmithKline Beecham p.l.c.
    Inventors: Robin Edwin Buckingham, Stephen Alistair Smith